COMPARISON OF CARDIOVASCULAR DISEASE EVENT RATES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS ACROSS 10 COUNTRIES - IMPLICATIONS FOR CV RISK ASSESSMENT

被引：0
|
作者：
Gabriel, S.
Crowson, C.
Matteson, E.
Kitas, G.
Douglas, K.
Sandoo, A.
Semb, A. G.
Rollefstad, S.
Ikdahl, E.
van Riel, P.
Arts, E.
Fransen, J.
Rantapaa-Dahlqvist, S.
Wallberg-Jonsson, S.
Innala, L.
Karpouzas, G.
Sfikakis, P.
Zampeli, E.
Dessein, P.
Tsang, L.
Gonzalez-Gay, M. A.
Corrales, A.
El-Gabalawy, H.
Hitchon, C.
Ramos, V. Pascual
Yanez, I. Contreras
Solomon, D.
Liao, K.
van de laar, M.
Vonkeman, H.
Meek, I.
Husni, E.
Overman, R.
Colunga, I.
Galarza, D.
机构：
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3556
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0135
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
  • [21] Actual and Perceived Risk of Cardiovascular Disease among Sample of Iraqi Patients with Rheumatoid Arthritis
    Hamoud, Istabraq Satam
    Jassim, Nizar Abdulateef
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2024, 13 (02): : 36 - 43
  • [22] PROSPECTIVE ASSESSMENT OF CARDIOVASCULAR RISK FACTORS IN RELATION TO DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Targonska-Stepniak, B.
    Piotrowski, M.
    Zwolak, R.
    Majdan, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 472 - 472
  • [23] Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients
    Xie, Fenglong
    Yun, Huifeng
    Levitan, Emily B.
    Muntner, Paul
    Curtis, Jeffrey R.
    ARTHRITIS CARE & RESEARCH, 2019, 71 (08) : 1004 - 1018
  • [24] PROTECTING THEIR HEART: CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Litwic, Anna E.
    Ledingham, Joanna M.
    RHEUMATOLOGY, 2010, 49 : I165 - I166
  • [25] Assessment of an intervention on cardiovascular risk factors in patients with rheumatoid arthritis
    Zacarias, Andrea
    Narvaez, Javier
    Rodriguez Moreno, Jesus
    Jordana, Montserrat
    Nolla, Joan M.
    Gomez Vaquero, Carmen
    MEDICINA CLINICA, 2016, 147 (03): : 109 - 112
  • [26] Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis
    Sattui, Sebastian E.
    Rajan, Mangala
    Lieber, Sarah B.
    Lui, Geyanne
    Sterling, Madeline
    Curtis, Jeffrey R.
    Mandl, Lisa A.
    Navarro-Millan, Iris
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (01) : 292 - 298
  • [27] Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis
    Targonska-Stepniak, Bozena
    Piotrowski, Mariusz
    Zwolak, Robert
    Drelich-Zbroja, Anna
    Majdan, Maria
    CARDIOVASCULAR ULTRASOUND, 2018, 16
  • [28] Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis
    Bożena Targońska-Stępniak
    Mariusz Piotrowski
    Robert Zwolak
    Anna Drelich-Zbroja
    Maria Majdan
    Cardiovascular Ultrasound, 16
  • [29] PREVALENCE OF CARDIOVASCULAR RISK FACTORS AND CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS PATIENTS ACROSS INTERNATIONAL REGIONS: A COMPARISON OF THE CORRONA INTERNATIONAL AND CORRONA US REGISTRIES
    Pappas, D. A.
    Lampl, K.
    Kremer, J. M.
    Radominski, S. C.
    Gal, J.
    Nyberg, F.
    Malaviya, A.
    Whitworth, A.
    Rillo, O. L.
    Gibofsky, A.
    Popkova, T. V.
    Ho, M.
    Laurindo, I.
    Reed, G. W.
    Kerzberg, E. M.
    Horne, L.
    Zahora, R.
    Saunders, K. C.
    Pons-Estel, B. A.
    Onofrei, A. U.
    Greenberg, J. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 639 - 639
  • [30] Tocilizumab and the risk for cardiovascular disease events among rheumatoid arthritis patients: A direct comparison in real-world setting
    Xie, Fenglong
    Yun, Huifeng
    Levitan, Emily
    Muntner, Paul
    Curtis, Jeffrey R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 47 - 48
12345